Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

U-PASS: unified power analysis and forensics for qualitative traits in genetic association studies.

Gao Z, Terhorst J, Van Hout CV, Stoev S.

Bioinformatics. 2020 Feb 1;36(3):974-975. doi: 10.1093/bioinformatics/btz637.

PMID:
31400194
2.

Western Medicine Versus Eastern Medicine: Do Both Have a Common Root, Scientific Background, and Worldwide Recognition?

Stefanov M, Stoev S, Kim J, Kim S.

Altern Ther Health Med. 2019 Jun 1. pii: AT5744. [Epub ahead of print]

PMID:
31221936
3.

Balkan Endemic Nephropathy - Still continuing enigma, risk assessment and underestimated hazard of joint mycotoxin exposure of animals or humans.

Stoev SD.

Chem Biol Interact. 2017 Jan 5;261:63-79. doi: 10.1016/j.cbi.2016.11.018. Epub 2016 Nov 18. Review.

PMID:
27871899
4.

Feed exposure to FB1 can aggravate pneumonic damages in pigs provoked by P. multocida.

Kovács M, Pósa R, Tuboly T, Donkó T, Repa I, Tossenberger J, Szabó-Fodor J, Stoev S, Magyar T.

Res Vet Sci. 2016 Oct;108:38-46. doi: 10.1016/j.rvsc.2016.07.011. Epub 2016 Jul 31.

PMID:
27663368
5.

Design and Characterization of Superpotent Bivalent Ligands Targeting Oxytocin Receptor Dimers via a Channel-Like Structure.

Busnelli M, Kleinau G, Muttenthaler M, Stoev S, Manning M, Bibic L, Howell LA, McCormick PJ, Di Lascio S, Braida D, Sala M, Rovati GE, Bellini T, Chini B.

J Med Chem. 2016 Aug 11;59(15):7152-66. doi: 10.1021/acs.jmedchem.6b00564. Epub 2016 Jul 28.

PMID:
27420737
6.

Foodborne mycotoxicoses, risk assessment and underestimated hazard of masked mycotoxins and joint mycotoxin effects or interaction.

Stoev SD.

Environ Toxicol Pharmacol. 2015 Mar;39(2):794-809. doi: 10.1016/j.etap.2015.01.022. Epub 2015 Feb 7. Review.

PMID:
25734690
7.

Inference for dynamic and latent variable models via iterated, perturbed Bayes maps.

Ionides EL, Nguyen D, Atchadé Y, Stoev S, King AA.

Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):719-24. doi: 10.1073/pnas.1410597112. Epub 2015 Jan 7.

8.

A comparative pathological finding in pigs exposed to fumonisin B1 and/or Mycoplasma hyopneumoniae.

Pósa R, Stoev S, Kovács M, Donkó T, Repa I, Magyar T.

Toxicol Ind Health. 2016 Jun;32(6):998-1012. doi: 10.1177/0748233714543735. Epub 2014 Aug 8.

PMID:
25107460
9.

EXTREME VALUE THEORY WITH OPERATOR NORMING.

Meerschaert MM, Scheffler HP, Stoev SA.

Extremes (Boston). 2013 Dec 1;16(4):407-428.

10.

Porcine/chicken or human nephropathy as the result of joint mycotoxins interaction.

Stoev SD, Denev SA.

Toxins (Basel). 2013 Sep 4;5(9):1503-30. doi: 10.3390/toxins5091503. Review.

11.

Food safety and increasing hazard of mycotoxin occurrence in foods and feeds.

Stoev SD.

Crit Rev Food Sci Nutr. 2013;53(9):887-901. doi: 10.1080/10408398.2011.571800. Review.

PMID:
23768181
12.

Use of computed tomography and histopathologic review for lung lesions produced by the interaction between Mycoplasma hyopneumoniae and fumonisin mycotoxins in pigs.

Pósa R, Magyar T, Stoev SD, Glávits R, Donkó T, Repa I, Kovács M.

Vet Pathol. 2013 Nov;50(6):971-9. doi: 10.1177/0300985813480510. Epub 2013 Mar 1.

PMID:
23456966
13.

Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.

Manning M, Misicka A, Olma A, Bankowski K, Stoev S, Chini B, Durroux T, Mouillac B, Corbani M, Guillon G.

J Neuroendocrinol. 2012 Apr;24(4):609-28. doi: 10.1111/j.1365-2826.2012.02303.x. Review.

14.

Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.

Corbani M, Trueba M, Stoev S, Murat B, Mion J, Boulay V, Guillon G, Manning M.

J Med Chem. 2011 Apr 28;54(8):2864-77. doi: 10.1021/jm1016208. Epub 2011 Mar 23.

15.

Experimental mycotoxic nephropathy in pigs provoked by a mouldy diet containing ochratoxin A and fumonisin B1.

Stoev SD, Gundasheva D, Zarkov I, Mircheva T, Zapryanova D, Denev S, Mitev Y, Daskalov H, Dutton M, Mwanza M, Schneider YJ.

Exp Toxicol Pathol. 2012 Nov;64(7-8):733-41. doi: 10.1016/j.etp.2011.01.008. Epub 2011 Feb 5.

PMID:
21296565
16.

Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.

Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I, Roux T, Bazin H, Bourrier E, Lamarque L, Breton C, Rives ML, Newman A, Javitch J, Trinquet E, Manning M, Pin JP, Mouillac B, Durroux T.

Nat Chem Biol. 2010 Aug;6(8):587-94. doi: 10.1038/nchembio.396. Epub 2010 Jul 11.

17.

Studies on carcinogenic and toxic effects of ochratoxin A in chicks.

Stoev SD.

Toxins (Basel). 2010 Apr;2(4):649-64. doi: 10.3390/toxins2040649. Epub 2010 Apr 12.

18.

Simultaneous occurrence of mycotoxins in human food commodities from Cameroon.

Njobeh PB, Dutton MF, Koch SH, Chuturgoon AA, Stoev SD, Mosonik JS.

Mycotoxin Res. 2010 Feb;26(1):47-57. doi: 10.1007/s12550-009-0039-6. Epub 2009 Dec 18.

PMID:
23605240
19.

Complex etiology and pathology of mycotoxic nephropathy in South African pigs.

Stoev SD, Denev S, Dutton MF, Njobeh PB, Mosonik JS, Steenkamp PA, Petkov I.

Mycotoxin Res. 2010 Feb;26(1):31-46. doi: 10.1007/s12550-009-0038-7. Epub 2009 Nov 17.

PMID:
23605239
20.
21.

Mycotoxic nephropathy in Bulgarian pigs and chickens: complex aetiology and similarity to Balkan endemic nephropathy.

Stoev SD, Dutton MF, Njobeh PB, Mosonik JS, Steenkamp PA.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010 Jan;27(1):72-88. doi: 10.1080/02652030903207227.

PMID:
19753495
22.

Contamination with storage fungi of human food from Cameroon.

Njobeh PB, Dutton MF, Koch SH, Chuturgoon A, Stoev S, Seifert K.

Int J Food Microbiol. 2009 Nov 15;135(3):193-8. doi: 10.1016/j.ijfoodmicro.2009.08.001. Epub 2009 Aug 9.

PMID:
19732987
23.
24.

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.

Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G.

Prog Brain Res. 2008;170:473-512. doi: 10.1016/S0079-6123(08)00437-8. Review.

PMID:
18655903
25.

Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.

Pena A, Murat B, Trueba M, Ventura MA, Bertrand G, Cheng LL, Stoev S, Szeto HH, Wo N, Brossard G, Serradeil-Le Gal C, Manning M, Guillon G.

Endocrinology. 2007 Sep;148(9):4136-46. Epub 2007 May 10.

PMID:
17495006
26.

Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.

Pena A, Murat B, Trueba M, Ventura MA, Wo NC, Szeto HH, Cheng LL, Stoev S, Guillon G, Manning M.

J Med Chem. 2007 Feb 22;50(4):835-47.

PMID:
17300166
27.

Experimental coccidiosis provoked by Eimeria acervulina in chicks simultaneously fed on ochratoxin A contaminated diet.

Koynarski V, Stoev S, Grozeva N, Mirtcheva T, Daskalov H, Mitev J, Mantle P.

Res Vet Sci. 2007 Apr;82(2):225-31. Epub 2006 Sep 25.

PMID:
16997337
28.

Design and synthesis of potent, highly selective vasopressin hypotensive agonists.

Stoev S, Cheng LL, Manning M, Wo NC, Szeto HH.

J Pept Sci. 2006 Sep;12(9):592-604.

PMID:
16625682
29.

Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.

Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N, Stoev S, Cheng LL, Manning M.

J Pept Sci. 2006 Mar;12(3):190-8.

PMID:
16130178
30.

Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.

Manning M, Cheng LL, Stoev S, Wo NC, Chan WY, Szeto HH, Durroux T, Mouillac B, Barberis C.

J Pept Sci. 2005 Oct;11(10):593-608.

PMID:
15880385
31.

Experimental mycotoxicosis in chickens induced by ochratoxin A and penicillic acid and intervention with natural plant extracts.

Stoev SD, Stefanov M, Denev S, Radic B, Domijan AM, Peraica M.

Vet Res Commun. 2004 Nov;28(8):727-46.

PMID:
15609872
32.

[Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].

Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N.

Akush Ginekol (Sofiia). 2004;43(1):20-3. Bulgarian.

PMID:
15168649
33.

The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations.

Guillon G, Derick S, Pena A, Cheng LL, Stoev S, Seyer R, Morgat JL, Barberis C, Gal CS, Wagnon J, Manning M.

J Neuroendocrinol. 2004 Apr;16(4):356-61. Review.

PMID:
15089974
34.

Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.

Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G.

J Med Chem. 2004 Apr 22;47(9):2375-88.

PMID:
15084136
35.

Experimental cadmium poisoning in sheep.

Stoev SD, Grozeva N, Simeonov R, Borisov I, Hubenov H, Nikolov Y, Tsaneva M, Lazarova S.

Exp Toxicol Pathol. 2003 Nov;55(4):309-14.

PMID:
14703778
36.

[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.

Derick S, Cheng LL, Voirol MJ, Stoev S, Giacomini M, Wo NC, Szeto HH, Ben Mimoun M, Andres M, Gaillard RC, Guillon G, Manning M.

Endocrinology. 2002 Dec;143(12):4655-64.

PMID:
12446593
37.

Studies on some feed additives giving partial protection against ochratoxin A toxicity in chicks.

Stoev SD, Djuvinov D, Mirtcheva T, Pavlov D, Mantle P.

Toxicol Lett. 2002 Sep 5;135(1-2):33-50.

PMID:
12243862
38.

Clinicomorphological studies in chicks fed ochratoxin A while simultaneously developing coccidiosis.

Stoev SD, Koynarsky V, Mantle PG.

Vet Res Commun. 2002 Apr;26(3):189-204.

PMID:
12090291
39.

Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors.

Terrillon S, Cheng LL, Stoev S, Mouillac B, Barberis C, Manning M, Durroux T.

J Med Chem. 2002 Jun 6;45(12):2579-88.

PMID:
12036367
40.

Experimental one year ochratoxin A toxicosis in pigs.

Stoev SD, Paskalev M, MacDonald S, Mantle PG.

Exp Toxicol Pathol. 2002 Feb;53(6):481-7.

PMID:
11926291
41.

Spontaneous mycotoxic nephropathy in Bulgarian chickens with unclarified mycotoxin aetiology.

Stoev SD, Daskalov H, Radic B, Domijan AM, Peraica M.

Vet Res. 2002 Jan-Feb;33(1):83-93.

42.

Design of oxytocin antagonists, which are more selective than atosiban.

Manning M, Stoev S, Cheng LL, Wo NC, Chan WY.

J Pept Sci. 2001 Sep;7(9):449-65.

PMID:
11587184
43.

Novel selective hypotensive vasopressin peptides: cardiovascular and structure-activity-relationship studies.

Chan WY, Levi R, Wo NC, Koyama M, Stoev S, Cheng LL, Manning M.

Eur J Pharmacol. 2001 May 4;419(1):65-72.

PMID:
11348632
44.

Experimental mycotoxic nephropathy in pigs provoked by a diet containing ochratoxin A and penicillic acid.

Stoev SD, Vitanov S, Anguelov G, Petkova-Bocharova T, Creppy EE.

Vet Res Commun. 2001 Apr;25(3):205-23.

PMID:
11334150
45.

Susceptibility to secondary bacterial infections in growing pigs as an early response in ochratoxicosis.

Stoev SD, Goundasheva D, Mirtcheva T, Mantle PG.

Exp Toxicol Pathol. 2000 Aug;52(4):287-96.

PMID:
10987179
46.

[Morphological diagnosis in gynecology: the joint activities of clinicians and pathologists].

Vasilev N, Daiev K, Nacheva A, Kovachev S, Stoev S, Anachkov K.

Akush Ginekol (Sofiia). 2000;39(1):52-6. Bulgarian. No abstract available.

PMID:
10826342
47.

Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays.

Chan WY, Wo NC, Stoev ST, Cheng LL, Manning M.

Exp Physiol. 2000 Mar;85 Spec No:7S-18S. Review.

PMID:
10795902
48.

Synthesis and biological activity of canavanine hydrazide derivatives.

Miersch J, Grancharov K, Pajpanova T, Tabakova S, Stoev S, Krauss GJ, Golovinsky E.

Amino Acids. 2000;18(1):41-59.

PMID:
10794131
49.

Influence of ochratoxin A and an extract of artichoke on the vaccinal immunity and health in broiler chicks.

Stoev SD, Anguelov G, Ivanov I, Pavlov D.

Exp Toxicol Pathol. 2000 Mar;52(1):43-55.

PMID:
10779152
50.

Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists.

Manning M, Stoev S, Cheng LL, Wo NC, Chan WY.

J Pept Sci. 1999 Nov;5(11):472-90.

PMID:
10587312

Supplemental Content

Support Center